Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Immunocore Holdings (IMCR) Receivables Refunds (2019 - 2025)

Immunocore Holdings' Receivables Refunds history spans 3 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Receivables Refunds changed N/A year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, changed N/A, while the annual FY2025 figure was $1.8 million, N/A changed from the prior year.
  • Receivables Refunds for Q4 2025 was $1.8 million at Immunocore Holdings, down from $3.5 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $9.2 million in Q4 2022 and bottomed at $1.8 million in Q4 2025.
  • The 3-year median for Receivables Refunds is $3.5 million (2023), against an average of $4.9 million.
  • The largest YoY upside for Receivables Refunds was 61.68% in 2023 against a maximum downside of 61.68% in 2023.
  • A 3-year view of Receivables Refunds shows it stood at $9.2 million in 2022, then tumbled by 61.68% to $3.5 million in 2023, then crashed by 48.79% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Receivables Refunds are $1.8 million (Q4 2025), $3.5 million (Q4 2023), and $9.2 million (Q4 2022).